Irish Journal of Medical Science

, Volume 179, Issue 4, pp 575–583 | Cite as

Evaluation of breast enlargement in young males and factors associated with gynecomastia and pseudogynecomastia

  • M. Yazici
  • M. SahinEmail author
  • E. Bolu
  • D. E. Gok
  • A. Taslipinar
  • S. Tapan
  • D. Torun
  • G. Uckaya
  • M. Kutlu
Original Article



Gynecomastia is defined as a palpable enlargement of the mammary gland in males that is distinguishable from lipomastia. The aim of this study was to assess the prevalence and characteristics of different causes of breast enlargement in young males referred to our tertiary center, and evaluation of the factors associated with gynaecomastia.

Materials and methods

One hundred thirty-five male recruits aged 20–30 years were enrolled in the study. A control group comprising 32 age-matched healthy individuals aged 20–25 years was also studied.


Idiopathic gynecomastia (IG) was diagnosed in 31 of 135 patients (23%) and Klinefelter’ syndrome (KS) was diagnosed in 70 cases (52%). Patients with KS had significantly higher body mass index (BMI) and waist and hip circumference waist/hip ratio than the control group. FSH, LH and SHBG were significantly higher and DHEAS, free testosterone (fT) and total testosterone (tT) were lower in patients with KS than the control group. Anthropometric measurements revealed significant increase in body weight and BMI in patients with IG compared with healthy controls. FSH and LH levels were significantly higher in the patients with IG. Patients with pseudogynecomastia alone were not obese and hypogonadism was observed in 35.1% of patients.


We concluded that gynaecomastia in young adult males is mostly because of KS or idiopathic in origin. IG seems to be the result of androgen resistance and in part increased aromatization because of increased adiposity. Symptoms or findings for hypogonadism must be evaluated carefully in patients with pseudogynecomastia. We also suggest that the presence of both gynecomastia and azoospermia necessitate further karyotypic analyses for KS.


Young men Gynecomastia Pseudogynecomastia Klinefelter’ syndrome Hypogonadism 


  1. 1.
    Heufelder AE, Leinung MC, Northcutt RC (1992) Holiday gynecomastia. Ann Intern Med 116:877 LetterPubMedGoogle Scholar
  2. 2.
    Lippens C, Ardies P, Van Steen A (1990) Pseudogynecomastia. J Belge Radiol 73:528–529PubMedGoogle Scholar
  3. 3.
    Behre HM, Yeung CH, Holstein AF, Weinbauer GF, Gassner P, Nieschlag E (2000) Diagnosis of male infertility and hypogonadism. In: Nieschlag E, Behre HM (eds) Andrology: male reproductive health and dysfunction, 2nd edn. Springer, Heidelberg, pp 90–124Google Scholar
  4. 4.
    Santen RJ (2006) Gynecomastia. In: Degroot LJ, Jameson JL (eds) Endocrinology, 5th edn. WB Saunders, Philadelphia, pp 3283–3293Google Scholar
  5. 5.
    Narula HS, Carlson HE (2007) Gynecomastia. Endocrinol Metab Clin N Am 36:497–519CrossRefGoogle Scholar
  6. 6.
    Bojesen A, Juul S, Gravholt CH (2003) Prenatal and postnatal prevalence of Klinefelter’ syndrome: a national registry study. J Clin Endocrinol Metab 88:622–626. doi: 10.1210/jc.2002-021491 CrossRefPubMedGoogle Scholar
  7. 7.
    Abramsky L, Chapple J (1997) 47,XXY (Klinefelter’ syndrome) and 47,XYY: estimated rates of and indication for postnatal diagnosis with implications for prenatal counselling. Prenat Diagn 17:363–368. doi: 10.1002/(SICI)1097-0223(199704)17:4<363::AID-PD79>3.0.CO;2-O CrossRefPubMedGoogle Scholar
  8. 8.
    Dejager S, Bry-Gauillard H, Bruckert E et al (2002) A comprehensive endocrine description of Kennedy’s disease revealing androgen insensitivity linked to CAG repeat length. J Clin Endocrinol Metab 87(8):3893–3901CrossRefPubMedGoogle Scholar
  9. 9.
    Schineider G, Kirschner MA, Bercowitz R, Ertel NH (1979) Increased estrogen production in obese men. J Clin Endocrinol Metab 48:633CrossRefGoogle Scholar
  10. 10.
    Georgiadis E, Papandreou L, Evangelopoulou C, Aliferis C, Lymberis C, Panitsa C, Batrinos M (1994) Incidence of gynecomastia in 954 young males and its relationship to somatometric parameters. Ann Hum Biol 21:579–587. doi: 10.1080/03014469400003582 CrossRefPubMedGoogle Scholar
  11. 11.
    MacDonald PC, Madden JD, Brenner PF, Wilson JD, Siiteri PK (1979) Origin of estrogen in normal men and in women with testicular feminization. J Clin Endocrinol Metab 49:905–916CrossRefPubMedGoogle Scholar
  12. 12.
    Niewoehner CB, Nuttall FQ (1984) Gynecomastia in a hospitalized male population. Am J Med 77:633–638CrossRefPubMedGoogle Scholar
  13. 13.
    Ley SB, mozaffarian GA, Leonard JM et al (1980) Palpable breast tissue versus gynecomastia as a normal physical finding. Clin Res 28:24AGoogle Scholar
  14. 14.
    Carlson HE (1980) Gynecomastia. N Engl J Med 303:795–799CrossRefPubMedGoogle Scholar
  15. 15.
    Nutall FQ (1979) Gynecomastia as a physical finding in normal men. J Clin Endocrinol Metab 48:338–340CrossRefGoogle Scholar
  16. 16.
    Bannayan GA, Hajdu SI (1972) Gynecomastia: clinicopathologic study of 351 cases. Am J Clin Pathol 57:431–437PubMedGoogle Scholar
  17. 17.
    Braunstein GD (1993) Gynecomastia. N Engl J Med 328:490–495. doi: 10.1056/NEJM199302183280708 CrossRefPubMedGoogle Scholar
  18. 18.
    Venta LA, Dudiak CM, Salomon CG, Flisak ME (1994) Sonographic evaluation of the breast. Radiographics 14:29–50PubMedGoogle Scholar
  19. 19.
    Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR (2001) Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore longitudinal study of aging. J Clin Endocrinol Metab 86:724–731. doi: 10.1210/jc.86.2.724 CrossRefPubMedGoogle Scholar
  20. 20.
    Orwoll E, Lambert LC, Marshall LM, Phips K, Blank J, Barrett-Connor E, Cauley J, Ensrud K, Cumming S (2006) Testosterone and estradiol among older men. J Clin Endocrinol Metab 91:1336–1344CrossRefPubMedGoogle Scholar
  21. 21.
    Behre HM, Nashan D, Nieschlag E (1989) Objective measurement of testicular volume by ultrasonography: evaluation of the technique and comparison with orchidometer estimates. Int J Androl 12:395–403. doi: 10.1111/j.1365-2605.1989.tb01328.x CrossRefPubMedGoogle Scholar
  22. 22.
    O’Connor S, Baker HW, Dulmansi A, Hudson B (1973) The measurement of sex steroid binding globulin by differential ammonium sulphate precipitation. J Steroid Biochem 4:331–339CrossRefPubMedGoogle Scholar
  23. 23.
    Nydick M, Bustos J, Dale JH Jr, Rawson RW (1961) Gynecomastia in adolescent boys. JAMA 178:449PubMedGoogle Scholar
  24. 24.
    Smyth CM, Bremner WJ (1998) Klinefelter’ syndrome. Arch Intern Med 158:1309–1314CrossRefPubMedGoogle Scholar
  25. 25.
    Lanfranco F, Kamischke A, Zitzmann M et al (2004) Klinefelter’ syndrome. Lancet 364:273–283CrossRefPubMedGoogle Scholar
  26. 26.
    Linden MG, Bender B, Robinson A (1996) Intrauterine diagnosis of sex chromosome aneuploidy. Obstet Gynecol 87:468–475CrossRefPubMedGoogle Scholar
  27. 27.
    Sorensen K, Nielsen J, Jacobsen P, Rolle T (1978) The 48,XXYY syndrome. J Med Genet 22:197–205Google Scholar
  28. 28.
    Klinefelter’ HF, Reifenstein EC, Albright F (1942) Syndrome characterized by gynecomastia, aspermatogenesis without Leydigism, increased excretion of follicle hormone stimulating hormone. J Clin Endocrinol 2:615–627CrossRefGoogle Scholar
  29. 29.
    Nieschlag E, Behre HM, Meschede D, Kamischke A (2000) Disorders at the testicular level. In: Nieschlag E, Behre HM (eds) Andrology: male reproductive health and dysfunction, 2nd edn. Springer, Heidelberg, pp 133–162Google Scholar
  30. 30.
    Griffin JE, Wilson JD (2002) Disorders of the testes and the male reproductive tract. In: Larsen PR, Kronenberg HM, Melmed S, Polonsky KS (eds) Williams textbook of endocrinology, 10th edn. Saunders, Philadelphia, pp 709–770Google Scholar
  31. 31.
    Kamischke A, Baumgardt A, Horst J, Nieschlag E (2003) Clinical and diagnostic features of patients with suspected Klinefelter’ syndrome. J Androl 24:41–48PubMedGoogle Scholar
  32. 32.
    Swerdlow AJ, Schoemaker MJ, Higgins CD et al (2005) Cancer incidence and mortality in men with Klinefelter’ syndrome: a cohort study. J Natl Cancer Inst 97(16):1204–1210CrossRefPubMedGoogle Scholar
  33. 33.
    Voors AW, Harsha DW, Webber LS, Berenson GS (1981) Obesity and external sexual maturation. The Bogalusa heart study. Prev Med 10:50–61CrossRefPubMedGoogle Scholar
  34. 34.
    Bauduceau B, Reboul P, Le Guyadec T, Legrelle M, Mayaudon H, Gautier D (1993) Hormonal profile of idiopathic gynecomastia in young adults. Apropos of 488 cases. Ann Endocrinol (Paris) 54(16):3–167Google Scholar
  35. 35.
    Ersöz H, Onde ME, Terekeci H, Kurtoglu S, Tor H (2002) Causes of gynaecomastia in young adult males and factors associated with idiopathic gynaecomastia. Int J Androl 25(5):312–316CrossRefPubMedGoogle Scholar
  36. 36.
    Sultan C, Bressot N, Garandeau P, Descomps B, Jean R (1980) Persistant pubertal gynecomastia. Biological study. La Semaine des Hopitaux 56:1923–1930PubMedGoogle Scholar
  37. 37.
    Veldhuis JD, Sowers JR, Rogol AD, Klein FA, Miller N, Dufau ML (1985) Pathophysiology of male hypogonadism associated with endogenous hyperestrogenism: evidence for dual defects in the gonadal axis. New Engl J Med 312:1371–1375CrossRefPubMedGoogle Scholar
  38. 38.
    Finkelstein JS, O’Dea LSTL, Whitcomb RW, Crowley WF (1991) Sex steroid control of gonadotropin secretion in the human male. II. Effects of estradiol administration in normal and gonadotropin-releasing hormone deficient men. J Clin Endocrinol Metab 73:621–628CrossRefPubMedGoogle Scholar
  39. 39.
    Jones TM, Fang VS, Landau RL, Rosenfield R (1978) Direct inhibition of Leydig cell function by estradiol. J Clin Endocrinol Metab 47:1368–1373CrossRefPubMedGoogle Scholar
  40. 40.
    Bulun SE, Noble LS, Takayama K, Michael MD, Agarwal V, Fisher C, Zhao Y, Hinshelwood MM, Ito Y, Simpson ER (1997) Endocrine disorders associated with inappropriately high aromatase expression. J Steroid Biochem Mol Biol 61:133–139. doi: 10.1016/S0960-0760(97)80004-0 CrossRefPubMedGoogle Scholar
  41. 41.
    Carlson HE, Kane P, Lei ZM et al (2004) Presence of luteinizing hormone/human chorionic gonadotropin receptors in male breast tissues. J Clin Endocrinol Metab 89:4119–4123. doi: 10.1210/jc.2003-031882 CrossRefPubMedGoogle Scholar
  42. 42.
    Bird J, Li X, Lei ZM et al (1998) Luteinizing hormone and human chorionic gonadotropin decrease type 2 5a-reductase and androgen receptor protein levels in women’s skin. J Clin Endocrinol Metab 83:1776–1782. doi: 10.1210/jc.83.5.1776 CrossRefPubMedGoogle Scholar

Copyright information

© Royal Academy of Medicine in Ireland 2009

Authors and Affiliations

  • M. Yazici
    • 1
  • M. Sahin
    • 1
    Email author
  • E. Bolu
    • 1
  • D. E. Gok
    • 1
  • A. Taslipinar
    • 1
  • S. Tapan
    • 2
  • D. Torun
    • 3
  • G. Uckaya
    • 1
  • M. Kutlu
    • 1
  1. 1.Department of Endocrinology and Metabolism, Gulhane School of MedicineGulhane UniversityAnkaraTurkey
  2. 2.Department of BiochemistryGulhane School of MedicineAnkaraTurkey
  3. 3.Department of Medical GeneticsGulhane School of MedicineAnkaraTurkey

Personalised recommendations